Growth Factors Market by Type (Bone Morphogenetic Proteins, Epidermal Growth Factors, Fibroblast Growth Factors), Product Form (Liquid Formulation, Lyophilized Powder), Source, Purification Grade, Delivery Method, Mode of Action, Application, End-User - G

Growth Factors Market by Type (Bone Morphogenetic Proteins, Epidermal Growth Factors, Fibroblast Growth Factors), Product Form (Liquid Formulation, Lyophilized Powder), Source, Purification Grade, Delivery Method, Mode of Action, Application, End-User - Global Forecast 2024-2030


The Growth Factors Market size was estimated at USD 2.13 billion in 2023 and expected to reach USD 2.27 billion in 2024, at a CAGR 7.96% to reach USD 3.64 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Growth Factors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Growth Factors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Growth Factors Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Akron Biotech, Applied Biological Materials Inc., Bio-Techne Corporation, Biopharm GmbH, Cell Guidance Systems, Cell Signaling Technology, Inc., Creative Bioarray, F. Hoffmann-La Roche AG, Gemini BioProducts LLC, Johnson & Johnson Services, Inc., Leadgene Biomedical, Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., Miltenyi Biotec B.V. & Co. KG, PeproTech, Inc., Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Repligen Corporation, Reprocell Inc., Rockland Immunochemicals, Inc., Sartorius CellGenix GmbH, Sino Biological, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage



This research report categorizes the Growth Factors Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Bone Morphogenetic Proteins
Epidermal Growth Factors
Fibroblast Growth Factors
Hepatocyte Growth Factors
Insulin-like Growth Factors
Nerve Growth Factors
Platelet-Derived Growth Factors
Transforming Growth Factors
Vascular Endothelial Growth Factors
Product Form
Liquid Formulation
Lyophilized Powder
Source
Animal-Derived Growth Factors
Recombinant Growth Factors
Purification Grade
Clinical Grade
Research Grade
Delivery Method
Implants
Injections
Topical Applications
Mode of Action
Angiogenic Growth Factors
Anti-Apoptotic Growth Factors
Mitogenic Growth Factors
Application
Cancer Treatment
Cardiovascular Disorders
Dental Applications
Dermatology
Neurological Disorders
Ophthalmology
Regenerative Medicine
Research & Development
Wound Healing
End-User
Biotechnology Companies
Cosmetic & Aesthetic Clinics
Dental Clinics
Hospitals & Clinics
Research Institutes & Academic Institutions
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Growth Factors Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Growth Factors Market?
3. What are the technology trends and regulatory frameworks in the Growth Factors Market?
4. What is the market share of the leading vendors in the Growth Factors Market?
5. Which modes and strategic moves are suitable for entering the Growth Factors Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Growth Factors Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand from the medical industry and enhanced usage in clinical applications
5.1.1.2. Incorporation of growth factors for regenerative medicine
5.1.2. Restraints
5.1.2.1. High cost of production and complex formulation process
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for the development of new growth factors
5.1.3.2. Immobilization of growth factors for cell therapy manufacturing
5.1.4. Challenges
5.1.4.1. Associated side effects and safety concerns
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Growth Factors Market, by Type
6.1. Introduction
6.2. Bone Morphogenetic Proteins
6.3. Epidermal Growth Factors
6.4. Fibroblast Growth Factors
6.5. Hepatocyte Growth Factors
6.6. Insulin-like Growth Factors
6.7. Nerve Growth Factors
6.8. Platelet-Derived Growth Factors
6.9. Transforming Growth Factors
6.10. Vascular Endothelial Growth Factors
7. Growth Factors Market, by Product Form
7.1. Introduction
7.2. Liquid Formulation
7.3. Lyophilized Powder
8. Growth Factors Market, by Source
8.1. Introduction
8.2. Animal-Derived Growth Factors
8.3. Recombinant Growth Factors
9. Growth Factors Market, by Purification Grade
9.1. Introduction
9.2. Clinical Grade
9.3. Research Grade
10. Growth Factors Market, by Delivery Method
10.1. Introduction
10.2. Implants
10.3. Injections
10.4. Topical Applications
11. Growth Factors Market, by Mode of Action
11.1. Introduction
11.2. Angiogenic Growth Factors
11.3. Anti-Apoptotic Growth Factors
11.4. Mitogenic Growth Factors
12. Growth Factors Market, by Application
12.1. Introduction
12.2. Cancer Treatment
12.3. Cardiovascular Disorders
12.4. Dental Applications
12.5. Dermatology
12.6. Neurological Disorders
12.7. Ophthalmology
12.8. Regenerative Medicine
12.9. Research & Development
12.10. Wound Healing
13. Growth Factors Market, by End-User
13.1. Introduction
13.2. Biotechnology Companies
13.3. Cosmetic & Aesthetic Clinics
13.4. Dental Clinics
13.5. Hospitals & Clinics
13.6. Research Institutes & Academic Institutions
14. Americas Growth Factors Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Growth Factors Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Growth Factors Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.2. Market Share Analysis, By Key Player
17.3. Competitive Scenario Analysis, By Key Player
18. Competitive Portfolio
18.1. Key Company Profiles
18.1.1. Abcam PLC
18.1.2. Akron Biotech
18.1.3. Applied Biological Materials Inc.
18.1.4. Bio-Techne Corporation
18.1.5. Biopharm GmbH
18.1.6. Cell Guidance Systems
18.1.7. Cell Signaling Technology, Inc.
18.1.8. Creative Bioarray
18.1.9. F. Hoffmann-La Roche AG
18.1.10. Gemini BioProducts LLC
18.1.11. Johnson & Johnson Services, Inc.
18.1.12. Leadgene Biomedical, Inc.
18.1.13. Lonza Group Ltd.
18.1.14. Merck KGaA
18.1.15. Meridian Bioscience Inc.
18.1.16. Miltenyi Biotec B.V. & Co. KG
18.1.17. PeproTech, Inc.
18.1.18. Prospec-Tany Technogene Ltd.
18.1.19. Proteintech Group, Inc.
18.1.20. Repligen Corporation
18.1.21. Reprocell Inc.
18.1.22. Rockland Immunochemicals, Inc.
18.1.23. Sartorius CellGenix GmbH
18.1.24. Sino Biological, Inc.
18.1.25. Thermo Fisher Scientific Inc.
18.2. Key Product Portfolio
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
FIGURE 1. GROWTH FACTORS MARKET RESEARCH PROCESS
FIGURE 2. GROWTH FACTORS MARKET SIZE, 2023 VS 2030
FIGURE 3. GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GROWTH FACTORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GROWTH FACTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GROWTH FACTORS MARKET DYNAMICS
FIGURE 7. GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GROWTH FACTORS MARKET SIZE, BY PRODUCT FORM, 2023 VS 2030 (%)
FIGURE 10. GROWTH FACTORS MARKET SIZE, BY PRODUCT FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 12. GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GROWTH FACTORS MARKET SIZE, BY PURIFICATION GRADE, 2023 VS 2030 (%)
FIGURE 14. GROWTH FACTORS MARKET SIZE, BY PURIFICATION GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
FIGURE 16. GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GROWTH FACTORS MARKET SIZE, BY MODE OF ACTION, 2023 VS 2030 (%)
FIGURE 18. GROWTH FACTORS MARKET SIZE, BY MODE OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 20. GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GROWTH FACTORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 22. GROWTH FACTORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 26. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 31. GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 32. GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings